We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$403M
AUM Growth
+$250M
Cap. Flow
+$235M
Cap. Flow %
58.3%
Top 10 Hldgs %
6.29%
Holding
793
New
457
Increased
87
Reduced
29
Closed
219

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.8M
2
TGT icon
Target
TGT
+$2.73M
3
LMT icon
Lockheed Martin
LMT
+$2.7M
4
DLTR icon
Dollar Tree
DLTR
+$2.53M
5
NOC icon
Northrop Grumman
NOC
+$2.29M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$2.59M
2
AAPL icon
Apple
AAPL
+$2.41M
3
CAG icon
Conagra Brands
CAG
+$1.87M
4
RHT
Red Hat Inc
RHT
+$1.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 21.61%
2 Consumer Discretionary 19.21%
3 Industrials 13.4%
4 Healthcare 12.85%
5 Financials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
726
Zimmer Biomet
ZBH
$19B
-5,070
Closed -$640K
ZD icon
727
Ziff Davis
ZD
$1.91B
-4,270
Closed -$247K
ZUMZ icon
728
Zumiez
ZUMZ
$298M
-15,900
Closed -$286K
CNH
729
CNH Industrial
CNH
$18.4B
-26,887
Closed -$169K
NVRO
730
DELISTED
NEVRO CORP.
NVRO
-4,833
Closed -$505K
EGRX
731
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-3,032
Closed -$212K
SWN
732
DELISTED
Southwestern Energy Company
SWN
-12,206
Closed -$169K
ALIM
733
DELISTED
Alimera Sciences
ALIM
-753
Closed -$17K
WRK
734
DELISTED
WestRock Company
WRK
-4,303
Closed -$209K
BFX
735
DELISTED
BowFlex Inc.
BFX
-9,129
Closed -$207K
MDRX
736
DELISTED
Veradigm Inc. Common Stock
MDRX
-17,990
Closed -$237K
AVID
737
DELISTED
Avid Technology Inc
AVID
-17,477
Closed -$139K
BBBY
738
DELISTED
Bed Bath & Beyond Inc
BBBY
-19,545
Closed -$843K
LCI
739
DELISTED
Lannett Company, Inc.
LCI
-4,169
Closed -$443K
ENDP
740
DELISTED
Endo International plc
ENDP
-36,600
Closed -$737K
CERN
741
DELISTED
Cerner Corp
CERN
-6,100
Closed -$377K
EPAY
742
DELISTED
Bottomline Technologies Inc
EPAY
-15,986
Closed -$373K
CONE
743
DELISTED
CyrusOne Inc Common Stock
CONE
-6,400
Closed -$304K
CSLT
744
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-12,377
Closed -$51K
GRUB
745
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-7,002
Closed -$602K
ZAGG
746
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-16,612
Closed -$135K
FIT
747
DELISTED
Fitbit, Inc. Class A common stock
FIT
-19,600
Closed -$291K
PE
748
DELISTED
PARSLEY ENERGY INC
PE
-20,512
Closed -$687K
AMAG
749
DELISTED
AMAG Pharmaceuticals
AMAG
-14,800
Closed -$363K
CBL
750
DELISTED
CBL& Associates Properties, Inc.
CBL
-20,300
Closed -$246K

Similar funds

Bayesian Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Bayesian Capital Management held 793 positions worth $403M, up 164% from $152M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Bayesian Capital Management deployed $235M of net new capital in Q4 2016, opening 457 new positions and adding to 87 existing holdings. Its largest new stake was Procter & Gamble: 32,800 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Zebra Technologies, an estimated $419K trimmed.

  • Bayesian Capital Management's largest Q4 2016 buy was Procter & Gamble: 32,800 shares worth $2.76M.
  • Bayesian Capital Management added most to Ross Stores in Q4 2016, an estimated $1.85M increase.
  • Bayesian Capital Management's biggest Q4 2016 reduction was Zebra Technologies, cutting an estimated $419K.
  • Bayesian Capital Management fully exited Adobe in Q4 2016, selling an estimated $2.59M.
  • Bayesian Capital Management's ten largest holdings make up 6.3% of its $403M portfolio in Q4 2016.
  • Bayesian Capital Management opened 457 new positions and closed 219 in Q4 2016.
  • Bayesian Capital Management's portfolio value rose 164% quarter-over-quarter to $403M.

Based on Bayesian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.